PIII Financials

Income Statement
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Revenue
386.4M
+0.4%
384.8M
+11.5%
345.3M
-3.0%
355.8M
-4.7%
373.2M
Cost of Revenue
336.0M
-21.1%
426.1M
+15.2%
369.8M
+5.2%
351.4M
-5.6%
372.0M
Gross Profit
50.4M
+222.1%
-41244000
-68.1%
-24536000
-652.9%
4.4M
+275.5%
1.2M
Operating Expenses
42.1M
-62.6%
112.6M
+472.1%
19.7M
-48.9%
38.6M
-1.8%
39.3M
R&D
SG&A
25.8M
-28.8%
36.2M
+61.7%
22.4M
-4.5%
23.4M
-6.9%
25.2M
Operating Income
8.2M
+105.4%
-153866000
-247.9%
-44223000
-29.6%
-34124000
+10.4%
-38088000
EBITDA
29.3M
+122.1%
-132871000
-473.0%
-23190000
-77.8%
-13041000
+23.5%
-17036000
Net Income
3.0M
+101.8%
-165714000
-138.6%
-69461000
-59.1%
-43665000
+1.3%
-44246000
EPS (Basic)
$0.37
+101.6%
$-23.08
-138.7%
$-9.67
-55.2%
$-6.23
+0.8%
$-6.28
EPS (Diluted)
$0.32
+101.4%
$-23.08
-138.7%
$-9.67
-55.2%
$-6.23
+0.8%
$-6.28
Shares (Diluted)
8.4M
+157.5%
3.3M
+0.0%
3.3M
+0.0%
3.3M
+0.2%
3.3M
P3 Health Partners (PIII) — Financials